WuXi Biologics hatches new baby with ADC drug unit IPO
The drug outsourcing services company is spinning off its WuXi XDC unit, seizing on investor enthusiasm for a new generation of highly targeted ADC drugs Key Takeaways: WuXi XDC has…
Recent Articles
RELATED ARTICLES
-
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK 603259.SHG -
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: WuXi XDC’s profit surges on growth in ADC market
2268.HK
-
FAST NEWS: WuXi XDC kicks off IPO with star cornerstone investors
2269.HK
-
FAST NEWS: JPMorgan boosts WuXi AppTec stake
2359.HK 603259.SHG
